The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNuformix Regulatory News (NFX)

Share Price Information for Nuformix (NFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.19
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.02 (11.111%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.19
NFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

7 Apr 2022 15:44

RNS Number : 6981H
Nuformix PLC
07 April 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BYW79Y38

Issuer Name

NUFORMIX PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An event changing the breakdown of voting

3. Details of person subject to the notification obligation

Name

CPI Enterprises Limited

City of registered office (if applicable)

Redcar

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

04-Apr-2022

6. Date on which Issuer notified

07-Apr-2022

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

3.750000

0.000000

3.750000

26600000

Position of previous notification (if applicable)

4.320000

0.000000

4.320000

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BYW79Y38

26600000

 

3.750000

 

Sub Total 8.A

26600000

3.750000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

 

 

 

 

Sub Total 8.B1

 

 

 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

 

 

 

 

 

Sub Total 8.B2

 

 

 

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

 

 

 

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

07-Apr-2022

13. Place Of Completion

Wilton, Redcar, UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLSSUFLWEESEDL
Date   Source Headline
10th Mar 20217:00 amRNSProposed Placing to raise £1.565 million
8th Mar 202112:00 pmRNSHolding(s) in Company
2nd Mar 20217:00 amRNSResearch Results
22nd Feb 20213:45 pmRNSHolding(s) in Company
10th Feb 20217:00 amRNSDirectorate Change
2nd Feb 20212:06 pmRNSSecond Price Monitoring Extn
2nd Feb 20212:01 pmRNSPrice Monitoring Extension
22nd Dec 20207:00 amRNSAppointment of Broker
22nd Dec 20207:00 amRNSHalf-year Report
7th Dec 20207:00 amRNSAppointment of Chief Executive Officer
2nd Dec 20207:00 amRNSAppointment of Non-Executive Director
24th Nov 20207:00 amRNSAppointment of Non-Executive Director
9th Nov 20202:06 pmRNSSecond Price Monitoring Extn
9th Nov 20202:01 pmRNSPrice Monitoring Extension
26th Oct 20202:16 pmRNSHolding(s) in Company
22nd Oct 20205:45 pmRNSHolding(s) in Company
22nd Oct 20204:16 pmRNSHolding(s) in Company
7th Oct 20207:00 amRNSPlacing and Strategic Update
24th Sep 20207:00 amRNSExclusive Option Agreement for NXP001
20th Aug 202011:33 amRNSResult of AGM
19th Aug 20204:41 pmRNSSecond Price Monitoring Extn
19th Aug 20204:36 pmRNSPrice Monitoring Extension
19th Aug 20202:24 pmRNSResults Pre-clinical Pilot Study in IPF for NXP004
28th Jul 202012:14 pmRNSAnnual Report and Notice of AGM 2020
22nd Jul 20207:00 amRNSPreliminary Results for year ended 31 March 2020
1st Jul 202011:15 amRNSNotification of Major Holdings
22nd Jun 20207:00 amRNSBoard Change
27th May 20202:06 pmRNSSecond Price Monitoring Extn
27th May 20202:00 pmRNSPrice Monitoring Extension
27th May 20207:00 amRNSBusiness Update
27th May 20207:00 amRNSNuformix and VistaGen Announce CNS Agreement
6th May 20203:30 pmRNSHolding(s) in Company
3rd Apr 20203:31 pmRNSHolding(s) in Company
30th Mar 20203:42 pmRNSNotiication of Major Share Holding
9th Mar 20204:42 pmRNSSecond Price Monitoring Extn
9th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Feb 20207:00 amRNSAppointment of Dr Karl Keegan
14th Feb 20204:41 pmRNSSecond Price Monitoring Extn
14th Feb 20204:35 pmRNSPrice Monitoring Extension
14th Feb 20202:05 pmRNSSecond Price Monitoring Extn
14th Feb 20202:00 pmRNSPrice Monitoring Extension
13th Feb 20204:40 pmRNSSecond Price Monitoring Extn
13th Feb 20204:35 pmRNSPrice Monitoring Extension
12th Feb 20204:10 pmRNSNotification of Major Holdings
5th Feb 20205:05 pmRNSOperational Update
5th Feb 20204:45 pmRNSResignation of Dave Tapolczay
5th Feb 20202:24 pmRNSDirector Dealing
5th Feb 20202:19 pmRNSNotification of Major Holdings
27th Jan 20207:00 amRNSResignation of John Lidgey
27th Jan 20207:00 amRNSMajor Shareholding Notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.